Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin-Reference-Cited by-同舟云学术

Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin

Published:2020-05-19 Issue:10 Volume:28 Page:993-1011
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Yang Fan¹,Xu Jiangkang¹,Fu Manfei¹,Ji Jianbo¹,Chi Liqun²,Zhai Guangxi¹

Affiliation:

1. Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, PR China;

2. Department of Pharmacy, Haidian Maternal and Child Health Hospital of Beijing, Beijing, PR China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2020.1766474

Reference182 articles.

1. Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

2. Clinical applications of nanomedicine in cancer therapy

3. Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer

4. Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles

5. Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential of surface-active copolymers on P123 micelles for drug solubility enhancement and in vitro cytotoxicity assay;Colloid and Polymer Science;2024-07-09

2. Tumor Microenvironment-Responsive Drug Delivery Based on Polymeric Micelles for Precision Cancer Therapy: Strategies and Prospects;Biomedicines;2024-02-11

3. Smart Polymeric Micelles for Anticancer Hydrophobic Drugs;Cancers;2022-12-20

4. Recent advances in synthesis, properties and applications of pH, light-responsive and functionalized surface active ionic liquids;Journal of Ionic Liquids;2022-12

5. Thioredoxin-1 Activation by Pterostilbene Protects Against Doxorubicin-Induced Hepatotoxicity via Inhibiting the NLRP3 Inflammasome;Frontiers in Pharmacology;2022-04-13